Neoplasms - Complications
Research News and Information

Saturday, November 21, 2009

Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer.

13 Dec 2009 BACKGROUND: New strains of methicillin-resistant Staphylococcus aureus (MRSA) which frequently carry the Panton-Valentine leukocidin (PVL) genes have been recognized to cause invasive infections in otherwise healthy children and adults. However, the ... Read more...

Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.

29 Sep 2009 PURPOSE: Bloodstream infection remains a major cause of morbidity and mortality in patients undergoing treatment for cancer. Severe infections due to Gram-negative bacilli & staphylococci are common in cancer patients. Altered gut flora because of ... Read more...

Antifungal prophylaxis with micafungin in patients treated for childhood cancer.

29 Sep 2009 BACKGROUND: Invasive fungal infections (IFIs) remain a major cause of infectious morality in neutropenic patients receiving chemotherapy or hematopoietic stem cell transplantation (HSCT). Micafungin exhibits broad antifungal activity against both ... Read more...

Latest indexed articles for 'Neoplasms - Complications'

These are the very latest articles for this heading:

• Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer. 13 Dec 2009
• The Canadian Triage Acuity Scale and oncological emergencies in the emergency department: the puzzle pieces may not fit. 29 Nov 2009
• Second primary cancers in survivors of childhood cancer. 29 Oct 2009
• [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter] 30 Sep 2009
• Proposed FDA rules on painkillers in U.S. Rile cancer community. 29 Sep 2009
• StatBite: cancer pain. 29 Sep 2009
• Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. 29 Sep 2009
• The Brief Pain Inventory: revealing the effect of cancer pain. 29 Sep 2009
• Antifungal prophylaxis with micafungin in patients treated for childhood cancer. 29 Sep 2009
• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009
• 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. 14 Sep 2009
• Cancer, clots and consensus: new understanding of an old problem. 12 Sep 2009
• Prevention of thrombosis in ambulatory patients with cancer. 12 Sep 2009
• Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. 6 Sep 2009
• Anticoagulation in the treatment of established venous thromboembolism in patients with cancer. 6 Sep 2009
• Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. 6 Sep 2009
• Prevention of venous thromboembolism in the cancer surgical patient. 6 Sep 2009
• Diagnosis and initial treatment of venous thromboembolism in patients with cancer. 6 Sep 2009
• New antithrombotic drugs: potential for use in oncology. 6 Sep 2009
• [Radiation therapy in elderly patients] 31 Aug 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl